The Relationship Between CD138 Count of Endometrium and Reproductive Outcome
NCT ID: NCT03689101
Last Updated: 2022-01-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
148 participants
INTERVENTIONAL
2016-03-21
2019-02-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Firstly, This study aims to explore the relationship between endometrial CD138 count and pregnancy outcome following frozen embryo transfer in natural cycles. Secondly , the investigators want to find a cut-off value which is related to reproduction outcome.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Transcriptome Profiling and Endometrial Receptivity
NCT03925311
Frozen Embryo Transfer Pregnancy Outcomes Prediction by Microbiome and Transcriptome
NCT05545631
Endometrial Local Injury to Improve the Outcome of Embryo Transfer
NCT02306395
Frozen Embryo Transfer Pregnancy Outcomes Prediction by Microbiome
NCT05521295
Chronic Endometritis and IVF
NCT02646930
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Endometrial biopsies
Endometrial biopsy was performed precisely 7 days after LH surge (LH+7) to count endometrial CD138.
Endometrial biopsies
Endometrial biopsy was performed precisely 7 days after LH surge (LH+7)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Endometrial biopsies
Endometrial biopsy was performed precisely 7 days after LH surge (LH+7)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* regular menstrual cycles;
* body mass index (BMI) ranged from 18 to 25
Exclusion Criteria
* intrauterine adhesions(moderate - severe), advanced endometriosis, adenomyosis, untreated hydrosalpinx, uterine fibroids (submucosal fibroids, nonmucosal fibroids \>4.0 cm and/or endometrial pressure)
20 Years
38 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Reproductive & Genetic Hospital of CITIC-Xiangya
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Fei Gong, doctor
Role: PRINCIPAL_INVESTIGATOR
Reproductive & Genetic Hospital of CITIC-Xiangya
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Reproductive & Genetic Hospital of CITIC-XIANGYA
Changsha, Hunan, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P2018009
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.